To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
1. Provide real world data on patient characteristics
Timeframe: Average of 3 years through study completion
2. Provide real world data on disease management
Timeframe: Average of 3 years through study completion
3. Provide real world data on healthcare utilization
Timeframe: Average of 3 years through study completion
4. Provide real world data on quality of care indicators
Timeframe: Average of 3 years through study completion
Provide real world data on cardiovascular outcomes in patients with type 2 diabetes; Chronic Kidney Disease and Heart Failure
Timeframe: Average of 3 years through study completion
6. Provide real world data on renal outcomes and other microvascular complications in patients with type 2 diabetes and Heart Failure
Timeframe: Average of 3 years through study completion
AstraZeneca Clinical Study Information Center